# AMICOMED

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amicomed

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.amicomed.com
- Latest round: Seed (Feb 13, 2017)
- Investors on record: 1

## About

AMICOMED Inc. specializes in digital health solutions that empower individuals to manage their blood pressure effectively through a CE-marked software system, enhancing communication with healthcare providers.Founded in 2015, AMICOMED Inc. is headquartered in San Francisco, US. The company focuses on developing innovative digital health technologies that assist users in monitoring and managing hypertension. Giangiacomo Di Torrepadula, the founder, has experience in healthcare technology, contributing to the company’s mission in addressing cardiovascular health. In February 2017, AMICOMED raised seed funding led by Launchpad Digital Health to further its initiatives.AMICOMED provides a digital health solution aimed at helping individuals monitor and manage their blood pressure through a CE-marked medical device software. The core offering allows users to track their blood pressure and heart rate, interpret trends, and communicate with healthcare professionals. This solution leverages data from CE-certified monitors to enhance users' understanding of their cardiovascular health, targeting the widespread issue of hypertension affecting over 1.28 billion adults globally. The primary users include adults diagnosed with hypertension and healthcare professionals in various European markets, including Germany, France, and the United Kingdom.AMICOMED operates on a subscription-based revenue model, offering users access to its platform via a monthly subscription plan. This model enables customers to utilize features such as trend analysis and personalized health insights, enhancing engagement in blood pressure management. The company may also partner with healthcare providers and institutions to widen access to its services. Pricing plans are tailored for both individual users and healthcare organizations, with the flagship product, AMICOMED, serving as the cornerstone of this model.AMICOMED plans to leverage its recent seed funding raised in February 2017 to expand its product offerings and enhance its service capabilities. The company is focused on launching new features that will further streamline user interaction and health tracking by the end of 2023. Additionally, AMICOMED aims to penetrate new geographic markets, specifically targeting expansions into Spain and Italy within the next two years, thereby increasing its footprint in Europe. The funding will support these initiatives and facilitate the development of new products that prioritize user engagement and healthcare collaboration.

## Funding rounds

- Seed, Feb 13, 2017 — Launchpad Digital Health

## Investors

- Launchpad Digital Health (https://capitalatlas.ai/funds/launchpad-digital-health) — Seed